Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Equity Average: 2011-2012

Historic Equity Average for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to $1.3 million.

  • Sonoma Pharmaceuticals' Equity Average rose 9629.63% to $1.3 million in Q4 2012 from the same period last year, while for Dec 2012 it was $1.3 million, marking a year-over-year increase of 9629.63%. This contributed to the annual value of $416,500 for FY2012, which is N/A change from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Equity Average of $1.3 million as of Q4 2012, which was up 1,752.20% from -$79,500 recorded in Q3 2012.
  • Over the past 5 years, Sonoma Pharmaceuticals' Equity Average peaked at $1.3 million during Q4 2012, and registered a low of -$352,500 during Q1 2012.
  • In the last 2 years, Sonoma Pharmaceuticals' Equity Average had a median value of $13,500 in 2011 and averaged $257,357.
  • The largest annual percentage gain for Sonoma Pharmaceuticals' Equity Average in the last 5 years was 9,629.63% (2012), contrasted with its biggest fall of 163.35% (2012).
  • Sonoma Pharmaceuticals' Equity Average (Quarterly) stood at $13,500 in 2011, then skyrocketed by 9,629.63% to $1.3 million in 2012.
  • Its Equity Average stands at $1.3 million for Q4 2012, versus -$79,500 for Q3 2012 and -$263,000 for Q2 2012.